Form 483s: Supplement Firms' Stage For Changing FDA Inspectors' Views
This article was originally published in The Rose Sheet
Executive Summary
Firms responding proactively to an FDA form 483 on GMP violations can ward off warning letters, say lawyers familiar with FDA inspections. Evidence of changes to standard operating procedures, detailed documentation and even photographs of changes in a facility can impact FDA’s next move.